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ABSTRACT
Malaria is one of the world’s deadliest infectious diseases,
with over 200 million infections and hundreds of thousands of
deaths annually. The malaria parasite Plasmodium berghei is a
complex protozoan organism that requires two hosts: the human,
site of asexual reproduction, and the Anopheles mosquito, where
sexual reproduction occurs. My research project seeks to
understand the antioxidant defense mechanisms P. berghei
employs to withstand the hostile extracellular environment of
the Anopheles mosquito vector through upregulation of 1Cysteine Peroxiredoxin (1-CPrx). When activated, defense gene
1-CPrx counteracts reactive oxygen species (ROS) released by the
mosquito as an immune response. Our goal is to determine the
mechanisms that allow the parasite to sense an environmental
change and respond through upregulation of 1-CPrx. We
hypothesize the activation of 1-CPrx promoter is driven by an
antioxidant response element (ARE), which upregulates the
defense gene.

BACKGROUND
To effectively bridge the gap from the intermediate human host
to the mosquito, Plasmodium must re-organize its cell biology to
adapt to the unique cellular conditions in each host. Migration
through the midgut of the mosquito is a dangerous feat
for Plasmodium, openly exposed to the mosquito’s defense
mechanisms; immersed in the mosquito’s blood meal,
Plasmodium faces threat of digestion and risk of damage by
cytotoxic reactive oxygen (ROS) and reactive nitrogen species
(RNS). To counteract the mosquito’s immune response,
Plasmodium upregulates specific antioxidant defense genes (Fig.
1). The Kanzok lab determined that one of these antioxidant
genes, 1-Cysteine Peroxiredoxin (1-CPrx), is strongly upregulated
by the parasite to combat exposure to ROS in the mosquito
midgut (Turturice et al 2013). Characterization of antioxidant
defense genes is of importance to us because they serve as
attractive targets for the development of transmission blocking
strategies to combat malaria. My objective is to determine the
location of the ARE in the promoter of 1-CPrx using a “promoterbashing” approach, established by former lab student Cecile
Swift. I will utilize a series of luciferase reporter constructs and
transfect them into P. berghei to study the 1-CPrx promoter.
Using this method, I will map the promoter of 1-CPrx to find the
location of the ARE and characterize the first inducible promoter
of the malaria parasite Plasmodium (Fig. 2).

RESULTS

Figure 2: Promoter contains Antioxidant Response
Elements (Swift et al., in prep)
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Figure 1: Plasmodium’s Regulation of Oxidative Stress Response via
1-CPrx Upregulation (Swift et al., in prep)

ONGOING PROJECT

Using the transfection protocol, pilot data
for 2.4kb and 1.0kb 1-CPrx promoter
fragments with comparable luciferase signals
were generated by Swift. Luminescence of the
1.0kb fragment indicates the presence of the
minimal promoter region. From Swift’s pilot
data, I have generated numerous plasmids
containing the 0.5kb and 1.0kb 1-CPrx
promoter fragments through bacterial
transformation to begin the process of locating
the ARE within the 1.0kb fragment. To ensure
the presence of the 1-CPrx gene of interest,
DNA samples were then subjected to restriction
digests using restriction enzyme KPNI, followed
by analytical gel electrophoresis of the digested
sample to confirm the bacteria had been
successfully transformed with the 1-CPrx
promoter fragments (Fig. 3).
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To generate results for my research project, I must create my
“molecular toolbox,” which involves (1) generation of excess
insert DNA (K fragments, removed from plain PDLC vector); (2)
generation of vector DNA—PDLC 0.5ΔK and PDLC 1.0 ΔK; (3)
practice handling, infecting, and exsanguinating mice to be
transfected with target DNA.
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Using the purified 1-CPrx promoter fragments, luciferase reporter
plasmids will be generated, followed by transfection of P. berghei with
reporter plasmids and subsequent quantification of the 1-CPrx
promoter in the luciferase assay. The reporter plasmid is transfected
into the parasite via electroporation, then the mouse is infected.
Activation of 1-CPrx leads to the subsequent activation of
the luc gene, generating luminescence; luminescence is quantified
using a luminometer relative to a control group (a Renilla luc protein
coupled to a control promoter). A truncated 1-CPrx gene containing
the promoter should yield a strong luminescence signal. Currently, I
have completed mouse training in the ACF and am learning how to
infect mice with parasites via intraperitoneal and tail-vein injections,
perform tail snips for blood smears, determine parasitemia, and
exsanguinate infected mice to obtain parasites. Once I have gained
more experience handling mice, I will transfect mice with my luciferase
reporter constructs. I will also use computational methods to analyze
the 1-CPrx promoter for potential transcription factor binding sites.
The goal is to determine the location of the ARE by generating
systematically smaller fragments and analyze resulting luminescence.
A fragment exhibiting no luminescence implies the inducible region is
no longer present. Once identified, I will screen
the Plasmodium genome for additional ARE sites on other genes.

DISCUSSION
My long-term goals will encompass a) removal of the putative TFbinding site from the parasite genome to determine whether 1-CPrx
expression is negatively affected and results in increased sensitivity to
ROS in the malaria parasite, b) using the TF-binding site as bait to
identify the transcription factor that binds to the TF-binding site and
regulates 1-CPrx expression, c) using computational methods to
screen the Plasmodium genome for presence of newly identified TFbinding site(s) and TFs. Localization of the ARE could be used to
determine the transcription factor that leads to its activation and will
provide new insight into the mechanism of antioxidant response
in Plasmodium.
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